Experts claim that low-calorie or zero-calorie sweeteners are safe food additives

Experts gathered at the XVIII Latin American Nutrition Congress (SLAN) defend the benefits and safety of low-calorie or zero-calorie sweeteners.   The Congress on low calorie sweetners This Congress is taking place in Guadalajara (Jalisco, México) since last Sunday until tomorrow, November 15th. A debate table came up about “The interest in low-calorie or zero-calorie…

Dry fruits: benefits and composition

Dry fruits are the missing component in our diet. Laura González, head of nutrition and health at Nestlé, explains how to incorporate them into our diet, refutes a few myths, talks about their composition and offers some guidelines for their consumption.     Link between dry fruits and the Mediterranean diet The main component of…

Tailoring cancer treatments to individual patients (Part 2 of 2)

Supercomputers help researchers design cancer models and predict treatments outcomes based on patient-specific conditions   Model Selection and Testing Over the years, many different mathematical models of tumor growth have been proposed, but determining which is most accurate at predicting cancer progression is a challenge. In October 2016, writing in Mathematical Models and Methods in…

Tailoring cancer treatments to individual patients (Part 1 of 2)

Supercomputers help researchers design cancer models and predict treatments outcomes based on patient-specific conditions Researchers have developed computer models to predict how cancer will progress in a specific individual, based on tissue, cellular and subcellular protein signaling responses. The models can predict how brain tumors (gliomas) will grow with much greater accuracy than previous models.…

Patient-derived organoids may help personalize the treatment of gastrointestinal cancers

A new review highlights the potential of 3-D organoid models derived from patient cells to help personalize therapy for individuals with gastrointestinal cancers. What are the organoids?    A new BJS (British Journal of Surgery) review highlights the potential of 3D organoid models derived from patient cells to help personalize therapy for individuals with gastrointestinal cancers.…